[Enhance – CANZ DEL] [Improve access to and – CANZ ADD] the appropriate use of antimicrobials [for humans and animals – UK ADD] through [the implementation of antimicrobial stewardship programmes and – EU ADD] [better valuation of and – US DEL] investment in [the development of new and improvement of existing – HOLY SEE ADD] innovative, rapid, [effective, validated – CANZ ADD] and affordable [esse. [...] [Underscore the environmental dimensions – EU DEL] [Acknowledge the role of the environment as source of and in the spread of – EU ADD] [and public health threat posed by discharge of antimicrobials and their metabolites into the environment and the need for a range of – CHE ADD] [antimicrobial resistance and the need for – CHE DEL] [multisectoral – EU ADD] priority actions to prevent and address. [...] Note with concern the inadequate [research and development pipeline for – EU DEL] [finance of transdisciplinary and One Health research and development needed for – EU ADD] vaccines, diagnostics, antimicrobials, and alternatives [to antimicrobials – UK ADD / to the use of antimicrobials especially to the use of antibiotics, and to develop innovative tools and methods, including social innovation –. [...] Recognize the benefits of public-private partnerships [such as CARB-X and the Global Antibiotic Research and Development Partnership, – CHE ADD] in the development of [and access to – CHE ADD] antimicrobials, [vaccines, diagnostics and alternatives to antimicrobials – UK ADD] [and in contributing to supply chain sustainability – US ADD], as well as addressing [regulations and – MEX ADD] barriers t. [...] Recognize the important role played by the [public and – EU ADD] private sector in research and development of innovative medicines [and new antimicrobials – EU ADD] and [increase support for the implementation of “delinkage” – EU ADD] [continue to support voluntary initiatives and incentive mechanisms – EU DEL] that separate the cost of investment in research and development from the price and vo.
Authors
- Pages
- 32
- Published in
- United States of America
Table of Contents
- Source new 2
- Source ARES713 p2 3
- Source based on ARES78280 p30 5
- Source new 7
- 22ALT. 8
- Human Health 17
- Source based on ARES785 and ARES75284 18
- Agriculture Animal Health 20
- Source new 22
- Source Strategy on Antimicrobial Resistance and the Prudent use of Antimicrobials WOAH 22
- Environment 23
- Source new 24
- Commitments 25
- CARB-X and the Global Antibiotic 26
- Research and Development Partnership CHE ADD 26
- 66bis. Note with concern that the lack of investment poor professional incentives and declining 26
- Source Leaving the Lab Tracking the Decline in AMR RD Professionals AMR Industry Alliance 29
- Commitments 31